IHAM
TARA icon

Integral Health Asset Management’s Protara Therapeutics TARA Stock Holding History

Integral Health Asset Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.73M Sell
1,500,000
-250,000
-14% -$1.19M 0.23% 73
2026
Q1 		$9.12M Sell
1,750,000
-500,000
-22% -$2.96M 0.44% 64
2025
Q4 		$12M Buy
2,250,000
+850,000
+61% +$4.73M 0.6% 54
2025
Q3 		$6.09M Hold
1,400,000
– – 0.41% 66
2025
Q2 		$4.24M Hold
1,400,000
– – 0.39% 59
2025
Q1 		$5.96M Hold
1,400,000
– – 0.63% 47
2024
Q4 		$7.39M Buy
+1,400,000
New +$4.52M 0.63% 52

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Integral Health Asset Management's TARA Position: Q2 2026 in Review

Integral Health Asset Management reduced its Protara Therapeutics (TARA) stake by 14% in Q2 2026, selling an estimated $1.19M and leaving 1,500,000 shares worth $5.73M. The position accounts for 0.23% of the portfolio, ranked #73.

Integral Health Asset Management first reported a position in TARA in Q4 2024 and has held it in 7 quarters since. The position peaked at $12M in Q4 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Integral Health Asset Management held 1,500,000 shares of Protara Therapeutics worth $5.73M as of Q2 2026.
  • Integral Health Asset Management sold 250,000 Protara Therapeutics shares in Q2 2026, an estimated $1.19M.
  • Protara Therapeutics made up 0.23% of Integral Health Asset Management's portfolio in Q2 2026, its #73 holding.
  • Integral Health Asset Management first reported a position in Protara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Integral Health Asset Management's Protara Therapeutics position peaked at $12M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.